A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

The adjusted incidence of transmission of influenza virus by day 5 that resulted in symptoms was 5.8% with baloxavir and 7.6% with placebo, but this difference was not significant (adjusted OR 0. ...

Discussão. Os vírus Coxsackie B, Echo vírus tipo 8, o vírus da caxumba, da gripe (influenza), da mononucleose infecciosa, da poliomielite, da varicela e a vacina contra hepatite B destacam-se como ...

Estado deve concluir ainda em junho documento exigido pelo Ministério da Saúde para liberação de recursos voltados ao reforço ...

Background Abundant, indirect epidemiological evidence indicates that influenza contributes to all-cause mortality and cardiovascular hospitalisations with studies showing increases in acute ...

Background The UK Department of Health recommends annual influenza vaccination for healthcare workers, but uptake remains low. For staff, there is uncertainty about the rationale for vaccination and ...

A Secretaria estadual de Saúde do Piauí (Sesapi) informou que já foram aplicadas 592.888 doses da vacina contra a influenza, correspondendo a uma cobertura vacinal de 47% da população. Diante desse ...

Influenza A virus infection causes a contagious respiratory illness that poses a threat to human health. However, there are limited anti-influenza A therapeutics available, which is further compounded ...

Anti-influenza Therapies Associated With a Cost–effectiveness of Less Than £30,000 per QALY for Seasonal and Post-exposure Influenza Prevention* References. Authors and Disclosures.